Overview

Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease

Status:
Completed
Trial end date:
2019-04-17
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of ID1201 in patients with mild Alzheimer's disease
Phase:
Phase 2
Details
Lead Sponsor:
IlDong Pharmaceutical Co Ltd